Correlation Between Viatris and TC BioPharm
Can any of the company-specific risk be diversified away by investing in both Viatris and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and TC BioPharm Holdings, you can compare the effects of market volatilities on Viatris and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and TC BioPharm.
Diversification Opportunities for Viatris and TC BioPharm
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Viatris and TCBP is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of Viatris i.e., Viatris and TC BioPharm go up and down completely randomly.
Pair Corralation between Viatris and TC BioPharm
Given the investment horizon of 90 days Viatris is expected to generate 0.2 times more return on investment than TC BioPharm. However, Viatris is 5.12 times less risky than TC BioPharm. It trades about 0.05 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.16 per unit of risk. If you would invest 1,157 in Viatris on September 3, 2024 and sell it today you would earn a total of 152.00 from holding Viatris or generate 13.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Viatris vs. TC BioPharm Holdings
Performance |
Timeline |
Viatris |
TC BioPharm Holdings |
Viatris and TC BioPharm Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Viatris and TC BioPharm
The main advantage of trading using opposite Viatris and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.Viatris vs. Catalent | Viatris vs. Bausch Health Companies | Viatris vs. Tilray Inc | Viatris vs. Takeda Pharmaceutical Co |
TC BioPharm vs. ZyVersa Therapeutics | TC BioPharm vs. Palisade Bio | TC BioPharm vs. Unicycive Therapeutics | TC BioPharm vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |